|
Buprenorphine in the Treatment of Opioid Dependence |
|
| Home > Resources > Bibliography > Special Treatment Populations: Chronic Pain Patients | |
Special Treatment Populations: Chronic Pain PatientsGureje O, Von Korff M, Simon GE, and Gater R. Persistent pain and well-being: A World Health Organization study in primary care. Journal of the American Medical Association (280):147–151, 1998. Hanks GW. The clinical usefulness of agonist-antagonist opioid analgesics in chronic pain. Drug and Alcohol Dependence (20):339–346, 1987. Houde RW, Wallenstein SL, Rogers A, and Kaiko RF. Annual report of the Memorial Sloan-Kettering Cancer Center Analgesic Studies Section. In: Proceedings of the 39th Annual Scientific Meeting, Committee on Problems of Drug Dependence 169–186, 1977. Wallenstein SL, Kaiko RF, Rogers AG, and Houde RW. Crossover trials in clinical analgesic assays: Studies of buprenorphine and morphine. Pharmacotherapy (6):228–235, 1986. Return to the table of contents. |
|
|
|
|
|
||
| Site Map | HHS Privacy Statement | Contact Us | Danya Learning Center | ||
| Developed by the American Academy of Addiction Psychiatry and Danya International with funding from the Center for Substance Abuse Treatment. | ||
| Last updated: September 20, 2002. | ||